Related Experiment Video
Updated: Jan 23, 2026

A Three-dimensional Tissue Culture Model to Study Primary Human Bone Marrow and its Malignancies
Published on: March 8, 2014
Second primary malignancies in postpolycythemia vera and postessential thrombocythemia myelofibrosis: A study on 2233
Barbara Mora1, Elisa Rumi2, Paola Guglielmelli3
1Hematology, Department of Medicine and Surgery, University of Insubria, Varese, Italy.
Abstract:
Patients with myeloproliferative neoplasms (MPN) are known to have higher incidence of nonhematological second primary malignancies (SPM) compared to general population. In the MYSEC study on 781 secondary myelofibrosis (SMF) patients, the incidence of SPM after SMF diagnosis resulted 0.98/100 patient-years. When including non-melanoma skin cancers (NMSC), the incidence arose to 1.56/100 patient-years. In SMF, JAK inhibitor treatment was associated only with NMSC occurrence. Then, we merged the MYSEC cohort with a large dataset of PV and ET not evolving into SMF. In this subanalysis, we did not find any correlation between SPM and SMF occurrence. These findings highlight the need of studies aimed at identifying MPN patients at higher risk of SPM.
Related Concept Videos
Bioavailability Study Design: Healthy Subjects Versus Patients
Primary Active Transport
Primary Active Transport
Primary and Secondary Growth in Roots and Shoots
Primary Distribution
Primary Production

